GSK (GSK) – Insiders' Blog
-
Complete Donald Trump Stock Impact Guide
-
GlaxoSmithKline to pay $20 million to settle U.S. foreign bribery case
-
How Pfizer has shifted U.S. profits overseas for years
-
Exclusive - Transatlantic divide: how U.S. pays three times more for drugs
-
GlaxoSmithKline (GSK) Antidepressant Paxil Found to Have Opposite Effects of Original Claims
-
WHO Gives Nod for Two Ebola Vaccine Trials in Liberia (NLNK) (MRK) (GSK)
-
NIH Offers Update on Progress of Ebola Treatments and Vaccines (NLNK) (CMRX) (BCRX)
-
BioMarin (BMRN) May Draw Interest Following Recent FDA Panel Vote (PFE) (RHHBY)
-
Glaxo (GSK) Appoints New China GM as Bribery Investigation Unfurls
-
Recnt Dip in Allergan (AGN) Shares Might Have Bidders Lining Up (GSK) (MRK)
-
Glaxo (GSK) Finds No Evidence of Corruption in Its China Sales Practices
-
Amarin (AMRN) Up as Vascepa Shows Strong Rx Growth Last Week
-
FDA panel votes 8-5 that breo ellipta helps reduce lung disease severity (THRX) (GSK)
-
Theravance (THRX) Trades Strong; Breo Briefing Docs Posted Ahead of Meeting (GSK)
-
Amarin (AMRN) Lower as Competitor Omthera Pharma (OMTH) Files IPO
-
Sarepta (SRPT) Pops Higher as Glaxo's DMD Drug Drisapersen Falters
-
InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength
-
Flu Vaccine Makers on Watch as U.S. Reaches Epidemic Level (GSK) (NVS) (SNY)
-
Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
-
Another Case Made for Amarin's (AMRN) Vascepa Missing NCE Status
-
Vertex (VRTX) Pops Higher, Enters Two New HCV Treatment Collaborations
-
Are Obesity Pills Hammering the Nail in Weight Watchers' (WTW) Coffin? Maybe Not...
-
Arena Pharma (ARNA) Higher as M&A Chatter Heats Up
-
Theravance (THRX) Trades Higher Following Positive Results from Four LAMA/LABA Phase IIIs
-
Merck (MRK) Has Attractive Dividend, Growth Potential - Barron's
-
Use the Sell-Off To Buy Warren Buffett's Accidental High-Yielders
-
Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
-
Q3 Preview: Merck (MRK) Trading Strong Into Earnings, Looks to Nearly Double-Up Revs Y/Y (PFE, GSK, SNY)
-
Buffett's Berkshire Nearly Doubles Stake in J&J (JNJ), Shows New Stake In Fiserv (FISV)
-
Wall Street Hubbub 7/26: A Genzyme (GENZ) Deal Coming, Is Biogen Idec (BIIB) Next, New BP CEO, Goldman Sachs the Movie
-
Human Genome (HGSI) Up On More Takeover Talk
-
Human Genome Sciences (HGSI) Climbs Higher On Takeover Speculation
-
Biocryst (BCRX) Falls After Company Left Out of CDC's Recommened Flu Drugs
-
Swine Flu Stocks Higher After China Becomes 1st Country To Issue Mass H1N1 Inoculation
-
Swine Flu Stocks Could Be Hot As Fears Grow and Vaccine Production Put In Motion
-
GlaxoSmithKline (GSK) And IRS Battle Regarding Back Due Taxes
-
Swine Flu Stock Rundown
-
U.S. Issues Public Health Emergency About Swine Flu
-
Buffett's Berkshire Slashes Stake in Johnson & Johnson (JNJ), Picks Up More NRG Energy (NRG)
-
Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News
-
Warren Buffett Accumulates NRG Energy (NRG) Stock; Raises Stakes in Ingersoll-Rand (IR) and Union Pacific (UNP)
-
Biotech Takeover Buzz Hot and Heavy After ImClone Offer (ONXX, OSIP, BIIB, AMLN, XPNT, CYPB, ISPH)
-
Berkshire Hathaway 13F: Boosts Stake in Kraft (KFT), Ingersoll-Rand (IR), Unitedhealth (UNH), Wells Fargo (WFC), US Bancorp (USB)
-
Major Drug Companies Fall to New 52-Week Lows (PFE, GSK, MRK, LLY, BMY)
-
Berkshire Hathaway 13F: Shows Big Kraft (KFT) Stake, Boosts Wells Fargo (WFC), Cuts Iron Mountain (IRM)
-
Buffett's Berkshire Shows 1.5M Share Stake in GlaxoSmithKline (NYSE: GSK)
Back to GSK Stock Lookup
